Overview
This is a 12 week double blind RCT aimed to investigate the role of omega-3 fatty acids in patients with major depressive disorder
Description
This is a 12 week double blind RCT aimed to investigate the role of omega-3 fatty acids in patients with major depressive disorder. Outcome measures including clinical symptoms, inflammation biomarkers and gut microbiota profiles.
Eligibility
Inclusion Criteria:
- Youth with a DSM-5 diagnosis of MDE
Exclusion Criteria:
- Has a recent change in antidepressants or psychotherapy treatment within 4 weeks.
- Allergic to omega-3 fatty acids